Compound Summary
Compound Information
FENRETINIDE
Compound Name: | FENRETINIDE |
Compound CID: | 5288209 |
Synonyms: | FENRETINIDE 65646-68-6 N-(4-Hydroxyphenyl)retinamide 4-HPR 4-hydroxyphenylretinamide More... |
Iupac Name: | (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide |
InChI: | InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+ |
InChIKey: | AKJHMTWEGVYYSE-FXILSDISSA-N |
Canonical Smiles: | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C |
Isomeric Smiles: | CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C |
Molecular Weight: | 391.5 |
Molecular Formula: | C26H33NO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
FENRETINIDE
Molecular Weight: | 391.5 |
Molecular Formula: | C26H33NO2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 29 |
Complexity: | 726 |
Synonyms
FENRETINIDE
| FENRETINIDE | FENRETINIDE |
|---|---|
FENRETINIDE |
65646-68-6 |
N-(4-Hydroxyphenyl)retinamide |
4-HPR |
4-hydroxyphenylretinamide |
4-Hydroxyphenyl retinamide |
Retinoic acid p-hydroxyanilide |
all-trans-4-Hydroxyretinanilide |
Fenretinida |
Fenretinidum |
McN-R-1967 |
4-hydroxy(phenyl)retinamide |
N-(4-Hydroxyphenyl)all-Trans Retinamide |
4HPR |
Retinoic acid p-hydroxyphenylamide |
Retinamide, N-(4-hydroxyphenyl)- |
UNII-187EJ7QEXL |
4-(hydroxyphenyl)retinamide |
15-(4-hydroxyphenyl)aminoretinal |
MFCD00792674 |
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide |
187EJ7QEXL |
CHEMBL7301 |
MLS002701698 |
CHEBI:42588 |
NSC-374551 |
NCGC00090752-03 |
DSSTox_CID_12005 |
DSSTox_RID_78900 |
DSSTox_GSID_32005 |
Fenretinidum Latin |
Fenretinida Spanish |
Fenretinide USAN:INN |
SMR001456303 |
CAS-65646-68-6 |
CCRIS 3260 |
SR-01000075917 |
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide |
BRN 5769490 |
SYT-101 |
CALIX4!-BIS-CROWN-6,95 |
ST-602 |
Fenretinide; 4-HPR |
Fenretinide (4-HPR) |
N-(4-Hydroxyphenyl)-all-trans Retinamide |
p-Hydroxyphenylretinamide |
Spectrum5_001939 |
Fenretinide (USAN/INN) |
4 HPR |
Lopac0_000625 |
SCHEMBL11703 |
SCHEMBL11704 |
BSPBio_001419 |
MLS001055399 |
MLS006010811 |
BML2-E08 |
N-(4-hydroxyphenyl)-retinamide |
DTXSID2032005 |
SCHEMBL15703189 |
CHEBI:92493 |
AMY9087 |
AOB6402 |
15-(4-Hydroxyanilino)retinal # |
HMS1361G21 |
HMS1791G21 |
HMS1989G21 |
HMS2089B17 |
HMS3261N12 |
HMS3402G21 |
HMS3412M06 |
HMS3676M06 |
Pharmakon1600-01505602 |
4-HPR;(4-Hydroxyphenyl)retinamide |
BCP06908 |
EX-A4102 |
ZINC3871023 |
Tox21_111007 |
Tox21_200989 |
Tox21_500625 |
1-enyl)nona-2,4,6,8-tetraenamide |
3670AH |
BDBM50092055 |
HSCI1_000112 |
NSC374551 |
NSC760419 |
s5233 |
AKOS024456572 |
Tox21_111007_1 |
CCG-204713 |
CS-0789 |
DB05076 |
LP00625 |
MK-4016 |
N-(4-hydroxyphenyl)retinamide, 4-HPR |
NSC 760419 |
NSC-760419 |
SDCCGSBI-0050606.P002 |
all-trans-n-(4-hydroxyphenyl)retinamide |
dimethyl-9-(2,6,6-trimethylcyclohex- |
IDI1_033889 |
Retinoic acid p-hydroxyanilide, >=95% |
NCGC00090752-01 |
NCGC00090752-02 |
NCGC00090752-04 |
NCGC00090752-05 |
NCGC00090752-06 |
NCGC00090752-07 |
NCGC00090752-09 |
NCGC00090752-10 |
NCGC00090752-11 |
NCGC00090752-12 |
NCGC00090752-20 |
NCGC00258542-01 |
NCGC00261310-01 |
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamide |
AS-59667 |
BP-13369 |
HY-15373 |
SMR000677938 |
AB0109574 |
EU-0100625 |
H1464 |
D04162 |
H 7779 |
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7- |
33819-EP2275420A1 |
33819-EP2295055A2 |
33819-EP2295406A1 |
33819-EP2295416A2 |
33819-EP2295426A1 |
33819-EP2295427A1 |
33819-EP2298748A2 |
33819-EP2298764A1 |
33819-EP2298765A1 |
33819-EP2305642A2 |
33819-EP2311453A1 |
33819-EP2311808A1 |
33819-EP2311829A1 |
AB00172992-07 |
646F686 |
A835178 |
Q5443576 |
SR-01000075917-1 |
SR-01000075917-4 |
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide |
(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide |
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide;Fenretinide |
2,6,8-Nonatetraenamide, N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl-, (all-E)- |
3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide |
N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraeneamide |
Experimental Data
FENRETINIDE
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -3 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
FENRETINIDE
Statistics Data
FENRETINIDE
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -3 | 1 | 1 |
Statistics Data Visualization
FENRETINIDE
